Simultaneous blockade of TIGIT and HIF-1α induces synergistic anti-tumor effect and decreases the growth and development of cancer cells.
Fathi M, Bahmanpour S, Barshidi A, Rasouli H, Karoon Kiani F, Mahmoud Salehi Khesht A, Izadi S, Rashidi B, Kermanpour S, Mokhtarian R, Karpisheh V, Hassannia H, Mohammadi H, Jalili A, Jadidi-Niaragh F.
Fathi M, et al. Among authors: mokhtarian r.
Int Immunopharmacol. 2021 Dec;101(Pt A):108288. doi: 10.1016/j.intimp.2021.108288. Epub 2021 Oct 29.
Int Immunopharmacol. 2021.
PMID: 34710844